Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.biospace.com/article/releases/generex-posts-recording-of-may-6-shareholder-conference-call-highlighting-its-ii-key-covid-complete-vaccine-and-its-go-forward-plans-for-revenue-producing-assets/?s=79
http://www.globenewswire.com/news-release/2020/11/23/2131844/0/en/Generex-and-NuGenerex-Immuno-Oncology-Ii-Key-SARS-CoV-2-Vaccine-Partner-Bintai-Kinden-Executes-its-Exclusive-Distribution-Licensing-Option-for-Australia-and-New-Zealand.html
https://seekingalpha.com/news/3638066-generex-biotechnology-inks-licensing-agreement-for-swine-flu-vaccine-candidate-in-china
https://www.globenewswire.com/news-release/2020/10/13/2107662/0/en/Generex-Subsidiary-NuGenerex-Immuno-Oncology-Announces-Publication-of-a-Review-Article-on-Cancer-Vaccines-Highlighting-AE37-Ii-Key-HER2-Immunotherapeutic-Vaccine.html
https://www.globenewswire.com/news-release/2020/04/28/2023410/0/en/Generex-Subsidiary-NuGenerex-Immuno-Oncology-Announces-Publication-of-Positive-Results-of-the-AE37-Phase-IIb-Breast-Cancer-Trial.html
https://www.globenewswire.com/news-release/2020/04/28/2023410/0/en/Generex-Subsidiary-NuGenerex-Immuno-Oncology-Announces-Publication-of-Positive-Results-of-the-AE37-Phase-IIb-Breast-Cancer-Trial.html